Faeth Therapeutics to Participate in Upcoming November Investor Conferences
Business Wire•11/11/2026•07:30 ET
0
Key Highlights
- ➤Faeth management to attend Guggenheim Healthcare Innovation Conference November 11, 2026
- ➤Faeth management to present at Jefferies Global Healthcare Conference November 17, 2026
- ➤PIKTOR combines serabelisib and sapanisertib for endometrial and breast cancer
Faeth Therapeutics to Participate in Upcoming November Investor Conferences
Faeth Therapeutics (Nasdaq: FTH), a clinical-stage oncology company developing multi-node therapies for cancer patients, including its lead program PIKTOR, today announced that management will participate in the following upcoming investor conferences:
Get started
Create a free account to read the full story.